Risk factors associated with earlier age of onset in familial pancreatic carcinoma

Cancer

Volumn 101, Issue 12, 2004, Pages 2722-2726

  James, Ted A ^a   Sheldon, David G ^a   Rajput, Ashwani ^a   Kuvshinoff, Boris W ^a   Javle, Milind M ^a   Nava, Hector R ^a   Smith, Judy L ^a   Gibbs, John F ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Age of onset; Hereditary disease; Pancreas; Smoking

Indexed keywords

ADULT; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; DEMOGRAPHY; FAMILIAL CANCER; FEMALE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SMOKING;

ADENOCARCINOMA; ADULT; AGE OF ONSET; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 10044251225     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20700     Document Type: Review

References (18)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7-33.
2. Lynch HT, Smyrk T, Kern SE, et al. Familial pancreatic cancer: a review. Semin Oncol. 1996;23:251-275.
3. Lynch HT, Fitzsimmons ML, Smyrk TC, et al. Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. Am J Gastroenterol. 1990;85:54-60.
4. Petersen GM, Hruban RH. Familial pancreatic cancer: where are we in 2003? J Natl Cancer Inst. 2003;95:180-181,
5. Hahn SA, Greenhalf B, Ellis I, et al. BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst. 2003;95:214-221.
6. Rulyak SJ, Lowenfels AB, Maisonneuve P, Brentnall TA. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology. 2003;124:1292-1299.
7. Klein AP, Beaty TH, Bailey-Wilson JE, Brune KA, Hruban RH, Petersen GM. Evidence for a major gene influencing risk of pancreatic cancer. Genet Epidemiol. 2002;23:133-149.
8. Tersmette AC, Petersen GM, Offerhaus GJ, et al. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res. 2001;7:738-744.
9. Lynch HT, Fusaro L, Lynch JF. Familial pancreatic cancer: a family study. Pancreas. 1992;7:511-515.
10. Luttges J, Stigge C, Pacena M, Kloppel G. Rare ductal adenocarcinoma of the pancreas in patients younger than age 40 years. Cancer. 2004;100:173-182.
11. Lal G, Liu G, Schmocker B, et al. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res. 2000;60:409-416.
12. Ozcelik H, Schmocker B, Di Nicola N, et al. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet. 1997;16:17-18.
13. Schenk M, Schwartz AG, O'Neal E, et al. Familial risk of pancreatic cancer. J Natl Cancer Inst. 2001;93:640-644.
14. Brentnall TA. Cancer surveillance of patients from familial pancreatic cancer kindreds. Med Clin North Am. 2000;84:707-718.
15. Rulyak SJ, Brentnall TA. Inherited pancreatic cancer: surveillance and treatment strategies for affected families. Pancreatology. 2001;1:477-485.
16. Wong T, Howes N, Threadgold J, et al. Molecular diagnosis of early pancreatic ductal adenocarcinoma in high-risk patients. Pancreatology. 2001;1:486-509.
17. Kekis PB, Friess H, Kleeff J, Buchler MW. Timing and extent of surgical intervention in patients from hereditary pancreatic cancer kindreds. Pancreatology. 2001;1:525-530.
18. Davis B, Lowy AM. Surgical management of hereditary pancreatic cancer. Med Clin North Am. 2000;84:749-759.